Top entities: Reklaim, Paul Sweeney, TSX Venture Exchange, Robert Fernicola, Brad Marks.

What category does this event fall under?

Business — classified as shareholder meeting.

What is the sentiment of coverage?

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Reklaim held annual general meeting · Reklaim approved omnibus incentive plan · Reklaim approved share-based compensation

Is this event still developing?

This is an active story, last updated Aug 12, 2026. Coverage continues to evolve.

Business shareholder meeting

Reklaim AGM approves incentive plan

Q: When did this event occur?

First reported Aug 12, 2026; last updated Aug 12, 2026.

Q: What is the market impact?

General. The approvals are routine corporate governance matters and are unlikely to significantly affect Reklaim's stock price.

Analysis based on 6 articles · First reported Aug 12, 2026 · Last updated Aug 12, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The approvals are routine corporate governance matters and are unlikely to significantly affect Reklaim's stock price. The re-approval of the equity incentive plan and share-based grants may slightly dilute existing shareholders but also aligns management incentives.

Data Privacy Software

Event Summary

Reklaim held its Annual General and Special Meeting of Shareholders on August 12, 2026, in Toronto. All matters submitted were approved. Shareholders fixed the number of directors at four and re-elected Paul Sweeney, Robert Fernicola, Brad Marks, and Jason Maguire as directors. They also re-appointed Davidson & Company LLP as auditors. The meeting re-approved the company's 10% rolling Omnibus Equity Incentive Plan, which provides a framework for granting stock options, RSUs, DSUs, and PSUs. Additionally, disinterested shareholders approved the June 30, 2026 share-based compensation grants, consisting of 3,581,999 stock options exercisable at $0.06 per share for three years and 1,099,999 RSUs at a deemed value of $0.04 per unit. The approvals align with TSX Venture Exchange requirements.

Key Actions

60 Reklaim held annual general meeting

50 Reklaim approved omnibus incentive plan

50 Reklaim approved share-based compensation

40 Reklaim re-elected directors

30 Reklaim re-appointed auditors Davidson & Company LLP

Entities Involved

stock

Reklaim

Reklaim held its AGM and received shareholder approval for all proposals, including the equity incentive plan and share-based compensation grants. This supports its ongoing operations and employee retention.

Importance 100.0 Sentiment 10.0

per

Paul Sweeney

Paul Sweeney was re-elected as a director and continues as CEO. His leadership remains central to Reklaim's strategy.

Importance 30.0 Sentiment 10.0

exch

TSX Venture Exchange

The TSX Venture Exchange is the listing exchange for Reklaim and its policies govern the approval process. The event is routine for the exchange.

Importance 20.0 Sentiment 0.0

per

Robert Fernicola

Robert Fernicola was re-elected as a director, continuing his board service.